Houttuynia cordata Thunb. is a medicinal plant widely used in traditional medicine and known for its diverse bioactive secondary metabolites. However, differences in metabolite composition between plant tissues and their functional implications remain unclear. This study assessed whether tissue-specific secondary metabolite profiles in H. cordata leaves and stems are associated with differences in antioxidant, anti-inflammatory and antibacterial activities. The botanical identification of the plant material was confirmed by matK gene sequencing. Gas chromatography-mass spectrometry (GC-MS) analysis revealed tissue-specific phytochemical distribution, with leaves enriched in biologically active compounds, whereas stems contained a greater number of detected compounds, indicating higher chemical diversity based on compound distribution within H. cordata. Both extracts exhibited dose-dependent anti-inflammatory activity through inhibition of nitric oxide (NO) production in RAW 264.7 macrophages; the stem extract showed stronger inhibitory potency, while the leaf extract demonstrated higher cell viability. The leaf extract also consistently exhibited higher antioxidant capacity in 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and ferric reducing antioxidant power (FRAP) assays. Furthermore, the leaf extract exerted stronger antibacterial activity and a broader inhibitory spectrum against Cutibacterium acnes, particularly among isolates from moderate to severe acne patients. These findings suggest that H. cordata may be associated with multiple biological effects related to bacterial growth, oxidative stress and inflammation, highlighting its potential relevance for developing herbal dermatological applications.
1 August 2026 in Journal of Pure and Applied Microbiology
Cutibacterium acnes is a dominant member of the human skin microbiota and is closely associated with the pathogenesis of acne vulgaris. The increasing emergence of antibiotic-resistant C. acnes strains has raised concerns regarding the long-term effectiveness of current therapies. This study aimed to characterize antibiotic susceptibility patterns and genomic features of C. acnes isolates obtained from healthy individuals and acne patients with different disease severities. A total of 45 participants were enrolled, including healthy controls and patients with mild and moderate-severe acne. C. acnes isolates recovered from pilosebaceous follicles were subjected to antibiotic susceptibility testing using the Kirby-Bauer disk diffusion method against five antibiotics including clindamycin, tetracycline, azithromycin, trimethoprim-sulfamethoxazole (TMP-SMX), and doxycycline. Representative isolates were selected for whole-genome sequencing, followed by multi-locus sequence typing (MLST) and antimicrobial resistance gene annotation. The results showed that most isolates remained highly susceptible to tetracycline-class antibiotics and TMP-SMX, whereas resistance to macrolides and clindamycin was detected, particularly among moderate-severe acne isolates. Genomic analysis revealed notable genetic diversity among the isolates and identified a single antimicrobial resistance gene, erm(51), consistent with the observed resistance phenotype. Overall, antimicrobial resistance in the analyzed C. acnes population was limited but detectable. The integration of phenotypic susceptibility testing with whole-genome analysis provides valuable insights for antimicrobial resistance surveillance and supports rational antibiotic use in acne management.